Early bone marrow transplantation in Hodgkin's disease
- 1 April 1994
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 5 (suppl_2) , S161-S163
- https://doi.org/10.1093/annonc/5.suppl_2.s161
Abstract
Bone marrow transplantation can be curative for patients with advanced Hodgkin's disease. Results are better when patients are transplanted after only one chemotherapy regimen at a time of minimal disease. Clinical trials are beginning testing bone marrow transplantation as part of the initial treatment for patients with widely disseminated, poor prognosis Hodgkin's disease.Keywords
This publication has 7 references indexed in Scilit:
- Autologous bone marrow transplantation for patients with relapsed hodgkin's diseaseThe American Journal of Medicine, 1991
- Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationBlood, 1989
- High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's diseaseBritish Journal of Cancer, 1989
- Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantationBlood, 1989
- High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.Journal of Clinical Oncology, 1988
- High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's diseaseBritish Journal of Cancer, 1986
- Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's DiseaseAnnals of Internal Medicine, 1982